Clinical Trial Update: High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose methotrexate in young patients with residual ependymoma is described (status not reported).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: UNKNOWN